Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 103

1.

Mirtazapine treatment of social phobia in women: a randomized, double-blind, placebo-controlled study.

Muehlbacher M, Nickel MK, Nickel C, Kettler C, Lahmann C, Pedrosa Gil F, Leiberich PK, Rother N, Bachler E, Fartacek R, Kaplan P, Tritt K, Mitterlehner F, Anvar J, Rother WK, Loew TH, Egger C.

J Clin Psychopharmacol. 2005 Dec;25(6):580-3.

PMID:
16282842
2.

Mirtazapine in generalized social anxiety disorder: a randomized, double-blind, placebo-controlled study.

Schutters SI, Van Megen HJ, Van Veen JF, Denys DA, Westenberg HG.

Int Clin Psychopharmacol. 2010 Sep;25(5):302-4.

PMID:
20715300
3.
4.

Study of the use of antidepressants for depression in dementia: the HTA-SADD trial--a multicentre, randomised, double-blind, placebo-controlled trial of the clinical effectiveness and cost-effectiveness of sertraline and mirtazapine.

Banerjee S, Hellier J, Romeo R, Dewey M, Knapp M, Ballard C, Baldwin R, Bentham P, Fox C, Holmes C, Katona C, Lawton C, Lindesay J, Livingston G, McCrae N, Moniz-Cook E, Murray J, Nurock S, Orrell M, O'Brien J, Poppe M, Thomas A, Walwyn R, Wilson K, Burns A.

Health Technol Assess. 2013 Feb;17(7):1-166. doi: 10.3310/hta17070.

5.

Mirtazapine in social anxiety disorder: a pilot study.

Van Veen JF, Van Vliet IM, Westenberg HG.

Int Clin Psychopharmacol. 2002 Nov;17(6):315-7.

PMID:
12409686
6.

Comparison of the effects of mirtazapine and fluoxetine in severely depressed patients.

Versiani M, Moreno R, Ramakers-van Moorsel CJ, Schutte AJ; Comparative Efficacy Antidepressants Study Group.

CNS Drugs. 2005;19(2):137-46.

PMID:
15697327
8.

Low-dose mirtazapine: a new option in the treatment of antipsychotic-induced akathisia. A randomized, double-blind, placebo- and propranolol-controlled trial.

Poyurovsky M, Pashinian A, Weizman R, Fuchs C, Weizman A.

Biol Psychiatry. 2006 Jun 1;59(11):1071-7. Epub 2006 Feb 21.

PMID:
16497273
9.

Efficacy of mirtazapine for the treatment of fibromyalgia without concomitant depression: a randomized, double-blind, placebo-controlled phase IIa study in Japan.

Miki K, Murakami M, Oka H, Onozawa K, Yoshida S, Osada K.

Pain. 2016 Sep;157(9):2089-96. doi: 10.1097/j.pain.0000000000000622.

10.

Prospective open-label pilot trial of mirtazapine in children and adolescents with social phobia.

Mrakotsky C, Masek B, Biederman J, Raches D, Hsin O, Forbes P, de Moor C, DeMaso DR, Gonzalez-Heydrich J.

J Anxiety Disord. 2008;22(1):88-97. Epub 2007 Feb 3.

PMID:
17419001
11.

Mirtazapine for obsessive-compulsive disorder: an open trial followed by double-blind discontinuation.

Koran LM, Gamel NN, Choung HW, Smith EH, Aboujaoude EN.

J Clin Psychiatry. 2005 Apr;66(4):515-20.

PMID:
15816795
12.
13.

Mirtazapine vs. placebo in posttraumatic stress disorder: a pilot trial.

Davidson JR, Weisler RH, Butterfield MI, Casat CD, Connor KM, Barnett S, van Meter S.

Biol Psychiatry. 2003 Jan 15;53(2):188-91.

PMID:
12547477
14.

Fluvoxamine treatment of social phobia (social anxiety disorder): a double-blind, placebo-controlled study.

Stein MB, Fyer AJ, Davidson JR, Pollack MH, Wiita B.

Am J Psychiatry. 1999 May;156(5):756-60.

PMID:
10327910
15.

Mirtazapine versus amitriptyline in the long-term treatment of depression: a double-blind placebo-controlled study.

Montgomery SA, Reimitz PE, Zivkov M.

Int Clin Psychopharmacol. 1998 Mar;13(2):63-73.

PMID:
9669186
16.

Mirtazapine compared with paroxetine in major depression.

Benkert O, Szegedi A, Kohnen R.

J Clin Psychiatry. 2000 Sep;61(9):656-63.

PMID:
11030486
17.

Mirtazapine versus venlafaxine in hospitalized severely depressed patients with melancholic features.

Guelfi JD, Ansseau M, Timmerman L, Kørsgaard S; Mirtazapine-Venlafaxine Study Group.

J Clin Psychopharmacol. 2001 Aug;21(4):425-31.

PMID:
11476127
18.

Mirtazapine for Choking Phobia: Report of a Pediatric Case.

Tanıdır C, Hergüner S.

J Child Adolesc Psychopharmacol. 2015 Oct;25(8):659-60. doi: 10.1089/cap.2015.0145. No abstract available.

PMID:
26485089
19.

Mirtazapine versus fluoxetine in the treatment of panic disorder.

Ribeiro L, Busnello JV, Kauer-Sant'Anna M, Madruga M, Quevedo J, Busnello EA, Kapczinski F.

Braz J Med Biol Res. 2001 Oct;34(10):1303-7.

20.

Mirtazapine in amphetamine detoxification: a placebo-controlled pilot study.

Kongsakon R, Papadopoulos KI, Saguansiritham R.

Int Clin Psychopharmacol. 2005 Sep;20(5):253-6.

PMID:
16096515

Supplemental Content

Support Center